May 31, 2013

The FDA launches first inquiry into medical iPhone app

Screen Shot 2013-05-31 at 6.16.44 PM.png The FDA this week launched its first investigation into an unregulated mobile medical app.
Medical diagnosis on-the-go offers a new opportunity for health entrepreneurs. But the FDA believes that patient safety is potentially at risk with some but not all of these apps. The agency has said that it wants stricter rules to govern these apps and devices. VentureBeat.

quotemarksright.jpgThe FDAs final guidance on mobile medical apps, when it comes, is expected to resolve some of the uncertainty that plagues health entrepreneurs who arent clear whether their app should be regulated.

The FDAs letter was sent to Biosense Technologies Private Ltd., an Indian company with an app called uChek, which is designed to work alongside commercially available urinalysis test pads, also known as dipsticks. A typical application for dipsticks is to test for urinary tract infections.

The app gets to work when you take a photo of a test strip (already FDA approved and made by Siemens AG and Bayer AG) with an iPhone camera. The technology can identify the concentrations of certain substances in those strips, and will deliver results to patients.
The FDAs letter to the makers of uChek is intended to serve as a warning to other developers with unregulated apps used in clinical settings. There are thousands of apps in the App Store that fall in the medical category.quotesmarksleft.jpg

Read more.

Google+ FaceBook Follow Me on Pinterest
Home | About | ArchivesCopyright © 2016